The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: Subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1

J. Chris Kingswood*, Sergiusz Jozwiak, Elena D. Belousova, Michael D. Frost, Rachel A. Kuperman, E. Martina Bebin, Bruce R. Korf, J. Robert Flamini, Michael H. Kohrman, Steven P. Sparagana, Joyce Y. Wu, Thomas Brechenmacher, Karen Stein, Noah Berkowitz, John J. Bissler, David N. Franz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint Dive into the research topics of 'The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: Subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1'. Together they form a unique fingerprint.

Medicine & Life Sciences